Immediate treatment post-debridement was crucial for optimal results
Reduced glucose production in the liver
We begin by evaluating your medical history, including any underlying health conditions such as type 2 diabetes, high blood pressure, or cardiovascular issues
Please note: Why is there a membership fee
New triple receptor agonists have recently been designed and have shown a prolonged duration of action, supporting the possibility of once-weekly administration in humans
Real-world data with behavioural support Second Natures peer-reviewed research, published in JMIR Formative Research (2025), showed that semaglutide, combined with registered dietitian support and a structured behaviour change programme, produced an average 19.1% weight loss at 12 months, with 77.7% of participants achieving at least 10% weight loss